Buy Keytruda (Pembrolizumab) Drug
Generic name : Pembrolizumab.
Trade name : Keytruda.
Keytruda is manufactured by Merck & Co., Inc.
Keytruda FDA Approval :
Keytruda first approved September 4th, 2014.
Keytruda Dosage form :
For injection: 50 mg, lyophilized powder in single-use vial for reconstitution.Injection: 100 mg/4 mL (25 mg/mL) solution in a single-use vial.
Keytruda Indications and Usage :
Indicated for unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 mutation positive, a BRAF inhibitor.
Keytruda (Pembrolizumab) availability in India
- You could import this medicine against import permit on Patient Name.
- Please contact ACT Lifesciences Private Limited for further information.